Skip to main content
Reports of Practical Oncology and Radiotherapy logoLink to Reports of Practical Oncology and Radiotherapy
. 2012 Jun 15;17(4):200–206. doi: 10.1016/j.rpor.2012.04.002

Accelerated partial breast irradiation using external beam radiotherapy—A feasibility study based on dosimetric analysis

Surega Anbumani a,, Siddanna R Palled b, Girish S Prabhakar a, N Arunai Nambiraj c, Anchineyan Pichandi a
PMCID: PMC3863155  PMID: 24377024

Abstract

Aim

To investigate the feasibility of using External Beam radiotherapy for accelerated partial breast irradiation by a comparative tumour and normal tissue dose volume analysis with that of high dose rate interstitial brachytherapy.

Background

Accelerated Partial Breast Irradiation (APBI) is more clinically appealing because of the reduced treatment course duration and the irradiated area. Brachytherapy application is more dependent on the clinician's expertise when it is practised free hand without image guidance and a template. It happens to be an invasive procedure with the use of local anaesthesia which adds patient discomfort apart from its cost compared to External Beam Radiotherapy. But APBI with brachytherapy is more commonly practised procedure compared to EBRT owing to its previous reults. Hence in this research study, we intend to explore the use of EBRT with the radiobiological corrections for APBI in the place of brachytherapy. It is done as a dosimetric comparison of Brachytherapy treatment plans with that of EBRT plans.

Materials and methods

The computed tomography images of 15 patients undergoing ISBT planning were simulated with conformal photon fields. Various dose volume parameters of each structure were obtained from the DVH generated in the brachytherapy and the simulated external beam planning which can correlate well with the late toxicity. The plan quality indices such as conformity index and homogeneity index for the target volume were computed from the dosimetric factors. The statistical p values for CI, HI and normal tissue dosimetric parameters were calculated and the confidence levels achievable were analysed. The dose prescribed in brachytherapy was 3400cGy in ten fractions. The equivalent prescription dose for the external beam radiotherapy planning was 3000cGy in five fractions applied with radiobiological correction.

Results

All the fifteen patients were with complete lung data and six were with left sided tumours having complete cardiac data. The lung dosimetry data and the cardiac dosimetry data of the patients were studied. Lower percentages of lung and cardiac V20 and V5 volumes were obtained with conformal planning. The conformity of radiation dose to the tumour volume was akin to the interstitial brachytherapy planning. Moreover the external beam planning resulted in more homogenous dose distribution. For the sampled population, the statistical analysis showed a confidence level of 95% for using EBRT as an alternate to multi catheter ISBT.

Conclusion

The EBRT planning for Accelerated Partial Breast Irradiation was found to be technically feasible in the institution where the interstitial brachytherapy happens to be the only available technique as evident from the dose volume parameters and the statistical analysis.

Keywords: APBI, Dose conformity, Dose homogeneity, Multicatheter ISBT

1. Background

Accelerated Partial Breast Irradiation (APBI) decreases the duration of entire radiotherapy course.1 The reduced treatment volume makes APBI more appealing to both clinicians and patients. The uses of brachytherapy either as HDR or LDR interstitial implants have shown promising results which are obvious from the published research works.2,3 But the interstitial implant technique can be more complex and operator dependent. The implant application is usually done with image guidance (Ultra sound/mammography images) using a template which plays a major role in ensuring uniform and accurate implants. Fewer oncologists prefer doing a free hand application without a template guidance which needs more expertise.

Radiobiological models based comparison of APBI techniques was done by Bovi J et al.4 Partial Breast Irradiation techniques for early stage breast carcinoma were evaluated by Agata et al.5 A dosimetric analysis was detailed by Cozzi et al. as a clinical experience of 3D conformal partial breast irradiation.6 Maia et al. and Vicini et al. studied the accelerated partial breast irradiation using photon fields.7,8 Dosimetric study of different accelerated partial breast irradiation techniques, such as 3DCRT, IMRT and Mammosite application, was evaluated by Khan AJ et al.9 Patel RR et al. dosimetrically compared the 3DCRT APBI with that of multi catheter interstitial implant brachytherapy for prone and supine position in helical tomotherapy.10

2. Aim

In this study, we explored the feasibility of using external beam radiotherapy using three dimensional conformal photon beams for APBI as an alternate practice to a freehand interstitial brachytherapy with dosimetrical and statistical analysis. The comparison was done with interstitial brachytherapy, since it is the only available APBI technique practiced at the institution.

3. Materials and methods

3.1. Patient selection

Fifteen patients undergoing the APBI with interstitial brachytherapy technique were enrolled and approved for the feasibility study.11 The patients underwent partial mastectomy and negative sentinel lymph node biopsy or axillary dissection for T1/T2 invasive duct carcinoma as a part of breast conservation surgery between July 2009 and October 2011 (see Table 1). Pre-treatment computed tomography images were taken as guidance to assess the distance of the tumour bed from the known landmarks or from the skin surface. The distances were marked on the patient body. Flexible plastic implant tubes were inserted into the tumour cavity as a free hand application.

Table 1.

Patient selection.

Pt. no Age (yrs) Rx site Lesion size (cm) No. of negative nodes Surgical margin
1 61 L Breast 3.0 20 −ve
2 70 R Breast 2.5 25 −ve
3 63 R Breast 1.9 20 −ve
4 65 R Breast 2.8 21 −ve
5 68 L Breast 3.0 23 −ve
6 71 L Breast 2.1 22 −ve
7 69 R Breast 2.7 25 −ve
8 70 R Breast 1.8 20 −ve
9 63 L Breast 1.6 23 −ve
10 61 L Breast 2.5 20 −ve
11 55 R Breast 3.0 22 −ve
12 58 R Breast 2.5 21 −ve
13 60 R Breast 2.7 24 −ve
14 62 R Breast 2.2 23 −ve
15 64 L Breast 1.2 22 −ve

3.2. Treatment planning

After the insertion of interstitial tubes, the patients underwent a CT simulation for the treatment planning. The CT images were sent to the PLATO treatment planning system (Version 14.2.6. NucletronBV, the Netherlands). The Clinical Target Volume was delineated as the lumpectomy cavity with a 2 cm margin, modified to 5 mm deep anterior to skin surface and also along the pectoral muscle.11 Critical organs such as ipsilateral lung and heart for left sided tumour were also marked. The contours were delineated by the same radiation oncologist. The catheters were reconstructed from skin entry to the skin exit in the axial CT images. Dwell positions (step size 2.5 mm) in the catheters were activated in such a way as to fall within the CTV marked. Dose points were computed at 3 mm intervals on the CTV delineated. A dose of 340cGy was prescribed to the target dose points. Then the volume based dose optimisation was done (Fig. 1). The dose volume histograms were generated for the target volumes and the critical structures.

Fig. 1.

Fig. 1

Multi catheter interstitial brachytherapy dose distribution-axial view.

With the implanted tubes in situ, an external beam therapy course was planned in the same CT images. The multiple beam arrangement was used with a combination of both coplanar and non coplanar beams.12–14 The plan data was tabulated in detail (Table 2). An optimal dose distribution with a better coverage and homogeneity was achieved using typical dose weightings with various wedge combination (Fig. 2). An analysis conducted on BED of different fractionation schemes based on available pre-clinical and clinical indications showed that the tumour control in breast carcinoma can be effective with a biological equivalent dose of 75 Gy.37 According to the LQ model formula, a dose of 30 Gy given in five fractions of 6 Gy over ten days was found to be radiobiologically equivalent in tumour control (75 Gy) to that of 50 Gy/25 fractions over five weeks.38 Hence, the dose prescribed was 600cGY × five fractions calculated using linear quadratic cell survival model.15,16 The five fractions were simulated as an alternate day schedule over ten days. Dose volume histograms were generated for all the structures (both target volume and normal tissues). Since the same CT data sets were used for simulating the EBRT plans, each patient served as their own internal control with respect to anatomy.

Table 2.

External beam plan parameters.

Pt. no Rx site No.of beams Energy Coplanar beams Non coplanar beams Wedge Weightings
1 L Breast 7 6 MV 240,10,70,290 20–250
30–320
300–30
28:7:7:30:9:9:9
2 R Breast 5 6 MV 55,345,270,231,196 15,45,45,15,45 40:04:04:40:12
3 R Breast 4 6 MV 345,40,115,165 28:24:24:24
4 R Breast 5 6 MV 40,0,280,230 270–320
20–250
266–35
300–30
30,30 20:20:20:20:20
5 L Breast 7 6 MV 225,275,0,60 45,30,30,45 28:7:7:30:9:9:9
6 L Breast 5 6 MV 320,357,141,160, 54 45,45,45 18:29:20:20:12
7 R Breast 6 6 MV 60,4,28,0,227 280–110
227–110
45,45,30,30 29:10:10:33:10
8 R Breast 6 6 MV 43,223,4,255 301–90
255–63
45,45 30:30:10:10:10:10
9 L Breast 5 6 MV 319,353,106,162, 55 15,45,45,15
15
32:12:12:33:12
10 L Breast 7 6 MV 238,8,60,280 20–245
30–320
298–25
27:8:8:29:9:9:9
11 R Breast 5 6 MV 50,340,270,230, 195 45,45,45,45,
45,45
35:5:5:30:15
12 R Breast 4 6 MV 340,35,115,160 20:20:20:20
13 R Breast 5 6 MV 53,345,270,235, 190 15,45,45,45
15
35:10:10:30:15
14 R Breast 6 6 MV 40,220,5,255 301–90
255–63
45,45 30:30:10:10:10:
15 L Breast 5 6 MV 320,355,140, 155, 53 45,45,45,45 20:20:30:15:15

Fig. 2.

Fig. 2

3D conformal EBRT dose distribution-coronal view.

3.3. Target volume dosimetry

From the Dose Volume Histogram generated from the brachytherapy plans (Fig. 3), the dosimetric parameters such as V100, V150 and V100 for the clinical target volume were obtained. Then the dose conformity index (CI) and the dose homogeneity index (HI) for the CTV were calculated from Eqs. (1) and (2) (Table 3).17

DHI=V100V150V100 (1)
CI=V100V100-V100 (2)

Fig. 3.

Fig. 3

Multi catheter interstitial brachytherapy-cumulative dose volume histogram.

Table 3.

CTV dosimetry.

Pt. no Interstitial brachytherapy planning
External beam palnning
V100 (cc) V150 (cc) V100 (cc) Vref (cc) C.I. H.I. D2 (cGy) D98 (cGy) PTV (cc) C.I. H.I.
1 27.4 13.2 5.8 33.2 0.8253 0.5182 30.94 28.22 25.5 0.768 1.096
2 115.02 21.82 36.48 151.5 0.7592 0.8102 30.66 28.84 129.2 0.853 1.063
3 145.61 93.59 389 149.5 0.9739 0.3572 32.70 29.52 134.5 0.900 1.107
4 27.51 24.61 0.09 27.6 0.9967 0.1054 33.20 28.64 22.08 0.800 1.159
5 22.70 8.45 8.10 30.8 0.7370 0.6277 31.78 28.14 26.55 0.862 1.129
6 64.91 33.91 2.59 67.5 0.9616 0.4775 32.32 29.84 64.24 0.9665 1.083
7 61.67 43.05 7.53 69.2 0.8911 0.3019 31.60 29.52 64.91 0.938 1.070
8 34.68 28.15 0.15 34.83 0.9956 0.1882 31.40 27.79 28.8 0.827 1.129
9 31.00 19.33 3.80 34.8 0.8908 0.3764 33.30 28.84 29.07 0.8355 1.154
10 30.16 27.14 0.28 35.6 1.009 0.1001 33.16 27.46 34.8 0.978 1.20
11 40.12 30.49 5.64 44.16 1.163 0.2400 32.12 28.48 43.89 0.994 1.128
12 32.13 30.12 6.14 35.75 1.236 0.0625 30.44 29.31 39.71 1.11 1.038
13 28.6 10.12 4.1 30.14 1.167 0.6462 32.60 30.10 32.55 1.08 1.083
14 28.61 20.16 0.5 29.16 1.0178 0.2953 33.15 29.10 30.62 1.05 1.139
15 55.65 40.05 6.00 60.17 1.1208 0.2803 31.48 27.64 59.51 0.989 1.138



Mean 0.9870 0.3591 Mean 0.9301 1.114

From the EBRT conformal plan dose volume histograms (Fig. 4), the planning target volume (PTV), reference volume (Vref), D2 and D98 were extracted. The dose conformity and homogeneity index were calculated from the Dosimetric values from Eqs. (3) and (4) 18 and tabulated (Table 3).

HI=D2D98 (3)
CI=PTVVref (4)

Fig. 4.

Fig. 4

3D conformal EBRT planning-cumulative dose volume histogram.

3.4. Normal tissue dosimetry

The dosimetric parameters such as Dmean, Dmax, D5 and V20 were obtained from the lung DVH generated in brachy planning and external beam planning (Table 3). The values of D20 and D30 from the heart DVH were also obtained in addition to Dmean, Dmax, D5 and V20 (Table 4). These parameters were taken into account since they correlate with late lung toxicity in patients receiving radiotherapy.19–24,34–36 Cardiac toxicity can be assessed with the available cardiac dosimetry data.20,25–27,34,36

Table 4.

Normal tissue dosimetry.

Dosimetric parameters External beam APBI
ISBT APBI
p-Value
Mean Range Mean Range
Lung n = 15
 Dmean Gy 5.1 3.2–12.2 4.0 2.0–6.14 0.047
 Dmax Gy 36.3 8.0–48.0 34.56 7.2–46.1 0.122
 V30 (%) 0.5% 0–1% 0.4% 0.0–0.65% 0.107
 V20 (%) 1.09% 0–3% 1.1% 0–2% 0.924
 V10 (%) 10% 0–15% 8.5% 0–14.1% 0.141
 D5 Gy 12.1 6.0–16 10.94 6.0–15.6 0.050
Heart n = 6
 Dmean Gy 3.2 2.7–5.1 2.8 1.7–4.8 0.089
 Dmax Gy 15.6 11.1–28.4 14.3 10.6–26.7 0.094
 V20 (%) 0.15% 0–0.5% 0.11% 0.0–0.4% 0.047
 V10 (%) 2.8% 0–8.2% 2.5% 0–8.0% 0.153
 V5 (%) 20.8% 11.5–31.6% 19.5% 9.6–30.1% 0.608
 D20 Gy 7.9 6.0–15.5 7.49 5.89–14.9 0.142
 D30 Gy 7.27 6.8–10.4 7.0 6.0–9.9 0.218

3.5. Statistical analysis

A summation and a mean calculation were done for the outlined dosimetric data. The paired two tailed student's t-tests were performed using Statistica 5.0 (Statsoft Inc) software to assess the significance of difference between the two groups. The p values for target dose conformity, dose homogeneity and normal tissue dosimetric parameters, such as Dmean, Dmax, D5, V20, D20, D30 for the normal tissues were computed and analysed (Table 4).

4. Results

The EBRT plans resulted in a more homogenous dose distribution. It is evident from the homogeneity index (p = 7.255) (Table 3 and Plot 1). The external beam planning resulted in a conformal dose distribution which was comparable to that of brachytherapy planning (p = 0.056) corresponding to a confidence interval of 95%. (Table 3 and Plot 2).

Plot 1.

Plot 1

Dose homogeneity index.

Plot 2.

Plot 2

Dose conformity index.

The incidental radiation dose to the lung and the heart using EBRT planning was similar to that of ISBT. A confidence level of 95% was obtained with all the computed dosimetric factors (Dmean, Dmax, D5, V20, D20, V5, V10 and D30) analysed, which supported the null hypothesis. Hence the normal tissue dosimetry in terms of conformal external beam planning with photon beams was comparable with brachy planning (Table 4).

5. Discussion

From this feasibility study, it was inferred that the simulated EBRT plans gave low doses of radiation to the critical organs, such as the lung and heart, which was comparable with the brachy planning. EBRT planning with conformal photon fields resulted in a very low percentage of volume receiving a dose of 20 Gy having a confidence level of 95% from the sampled population, which correlates with the lower incidence of lung toxicity.26,28,29,31–35 There was no prominent difference in heart maximum and minimum dose in both treatment planning techniques.

The dose conformity index (CI) and the dose homogeneity index (HI) are the quality indicators of the best treatment plan. Conformity index measures the degree of conformity of the radiation dose prescribed to the clinical target volume. Ideally, CI should be unity or the nearest value to unity in case of a better treatment plan. More conformal dose distribution can be achieved with the use of multiple photon beams which gives an analogous dose distribution as brachytherapy treatment plans (Table 3 and Plot 2).

Homogeneity index (HI) measures the radiation dose uniformity in the clinical target volume. The HI values calculated from the EBRT plans showed the values nearing to one (Table 3 and Plot 1), which is ideal for a homogenous dose distribution. Brachytherapy dose distributions are more heterogeneous around the catheter in nature which results in a poor cosmetic effect in the patients. Hence, it is of major concern in the brachytherapy, particularly when a free hand application happens to be the only available option in the institution.

The use of EBRT in APBI resulted in more homogenous dose distribution without compromising the dose conformity. The critical organ doses were also minimal which was similar to the dose distribution achieved with brachytherapy interstitial implants. It was clearly manifested by statistically less significant p values and optimal confidence level (t0.975 or t = 0.05) attained with the dose volume parameters.

The dose escalation of about 600cGy per fraction with conformal external beam radiotherapy paves the way for a better tumour control. Hence, it can be treatment of choice when a non invasive procedure is preferred. The set up uncertainties in the external beam radiotherapy procedure can be effectively overcome by daily treatment verification methods (Port films, EPID), immobilisation devices and with an added target volume margins.

6. Conclusions

This is a small sub set treatment planning feasibility study comprising of fifteen patient cases simulated with EBRT plans. The dose distribution planned was compared with the high dose rate brachytherapy planning. It gives satisfying results of dose conformity and dose homogeneity to the tumour volume with acceptable sparing of normal tissues based on the statistical analysis. Hence, the APBI can be effectively planned using the three dimensional conformal external beam radiation therapy. Patient discomfort during brachytherapy procedures involving sedation and a poor cosmetic effect after irradiation can be avoided. Conformal EBRT course is more cost effective when compared to brachytherapy. Hence, it can be suggested as an alternative treatment modality where brachytherapy procedures are performed freehand which is tedious in nature. Enduring research will focus on the evaluation of Tumour Control Probability and Normal Tissue Complication Probability in EBRT and brachytherapy plans.

Conflict of interest

None declared.

References

  • 1.Sanders M.E., Scroggins T., Ampil F.L. Li BD: APBI in early-stage breast cancer. J Clin Oncol. 2007;25(8):996–1002. doi: 10.1200/JCO.2006.09.7436. [DOI] [PubMed] [Google Scholar]
  • 2.Arthur D.W., Koo D., Zwicker R.D. Partial breast brachytherapy after lumpectomy: Low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys. 2003;56(3):681–689. doi: 10.1016/s0360-3016(03)00120-2. [DOI] [PubMed] [Google Scholar]
  • 3.Baglan K.L., Martinez A.A., Frazier R.C. The use of high-doserate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving surgery. Int J Radiat Oncol Biol Phys. 2001;50(4):1003–1011. doi: 10.1016/s0360-3016(01)01547-4. [DOI] [PubMed] [Google Scholar]
  • 4.Bovi J., Qi X.S., White J., Li X.A. Comparison of three APBI techniques: treatment effectiveness based upon biological models. Radiother Oncol. 2007;84(3):226–232. doi: 10.1016/j.radonc.2007.07.004. [DOI] [PubMed] [Google Scholar]
  • 5.Kacprowska A., Jassem J. Partial breast irradiation in early breast cancer. Rep Pract Oncol Radiother. 2011;16(6):213–220. doi: 10.1016/j.rpor.2011.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Cozzi L., Fogliata A., Nicolini G., Rancati T., Bernier J. Clinical experience on breast irradiation with a 3D conformal technique using three photon fields. Overview and dosimetric analysis. Acta Oncol. 2004;43:558–566. doi: 10.1080/02841860410015280. [DOI] [PubMed] [Google Scholar]
  • 7.Maia D., Elodie T., Charlotte P. 3D-conformal APBI treatment planning: the value of surgical clips in the delineation of the lumpectomy cavity. Radiat Oncol. 2009;4:70. doi: 10.1186/1748-717X-4-70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Vicini F.A., Kestin L., Chen P., Benitez P., Goldstein N.S., Martinez A. Limited-field radiation therapy in the management of early stage breast cancer. J Natl Cancer Inst. 2003;95(1205–1210):18. doi: 10.1093/jnci/djg023. [DOI] [PubMed] [Google Scholar]
  • 9.Khan A.J., Kirk M.C., Mehta P.S. A dosimetric comparison of three-dimensional conformal, intensity-modulated radiation therapy and Mammosite partial-breast irradiation. Brachytherapy. 2006;5:183–188. doi: 10.1016/j.brachy.2006.06.001. [DOI] [PubMed] [Google Scholar]
  • 10.Patel R.R., Becker S.J., Das R.K., Mackie T.R. A dosimetric comparison of accelerated partial braest irradiation techniques: multicatheter interstitial brachytherapy, three dimensional conformal radiotherapy, and supine versus prone helical tomotherapy. Int J Radiat Oncol Biol Phys. 2007;68(3):935–942. doi: 10.1016/j.ijrobp.2007.03.005. [DOI] [PubMed] [Google Scholar]
  • 11.Csaba Polgár, Erik Van Limbergen, Richard Pötter et al., Vratislav Strnad: Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving urgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence; 2009. [DOI] [PubMed]
  • 12.Formenti S.C. External beam partial breast irradiation. Semin Radiat Oncol. 2005;15:92–99. doi: 10.1016/j.semradonc.2004.10.008. [DOI] [PubMed] [Google Scholar]
  • 13.Nicolini G., Fogliata A., Cozzi L. Critical appraisal of a non-coplanar technique for radiotherapy of breast minimising lung involvement. Radiotherapy Oncol. 2005;76(3):319. doi: 10.1016/j.radonc.2005.04.009. [DOI] [PubMed] [Google Scholar]
  • 14.Yashar C., White G., Rice R., Pawlicki T. Evaluation of three APBI techniques under NSABP B-39 guidelines. J Appl Clin Med Phys. 2010;11(1):274–280. doi: 10.1120/jacmp.v11i1.3021. Winter. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Joiner M.C., van der Kogel A.J. The linear quadratic approach to fractionation and calculation of isoeffect relationships. In: Steel G.G., editor. Basic clinical radiobiology. 3rd ed. Arnold; London: 1997. pp. 106–122. [Google Scholar]
  • 16.van der Kogel A.J. Radiation response and tolerance of normal tissues. In: Steel G., editor. Basic clinical radiobiology. 2nd ed. Arnold; London: 1997. pp. 30–39. [Google Scholar]
  • 17.Wu A., Ulin K., Sternik E.S. A dose homogeneity index for evaluating Ir 192 Interstitial implants. MedPhys. 1988;15:104–107. doi: 10.1118/1.596152. [DOI] [PubMed] [Google Scholar]
  • 18.Sharma D.S., Gupta T., Jalali R., Master Z., Phurailatpam R.D., Sarin R. High precision radiotherapy for craniospinal irradiation, evaluation of 3D conformal radiotherapy IMRT and helical tomotherapy. BJR. 2009;82:1000–1009. doi: 10.1259/bjr/13776022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Chen P.Y., Vicini F.A., Benitez P. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer. 2006;106(5):991–999. doi: 10.1002/cncr.21681. [DOI] [PubMed] [Google Scholar]
  • 20.Stewart1 A.J., O’Farrell D.A., Cormack R.A. Dose volume histogram analysis of normal structures associated with APBI delivered by high dose rate brachytherapy and comparison with whole breast external beam radiotherapy fields. Radiat Oncol. 2008;3:39. doi: 10.1186/1748-717X-3-39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Evans E.S., Prosnitz R.G., Yu X. Impact of patient specific factors, irradiated left ventricular volume and treatment set-up errors on the development of myocardial perfusion defects after radiation therapy for left-sided breast cancer. Int J Radiat Oncol Biol Phys. 2006;66(4):1125–1134. doi: 10.1016/j.ijrobp.2006.06.025. [DOI] [PubMed] [Google Scholar]
  • 22.Yorke E.D., Jackson A., Rosenzweig K.E. Dose-volume factors contributing to the incidence of radiation pneumonitis innon-small-cell lung cancer patients treated with threedimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys. 2002;54(2):329–339. doi: 10.1016/s0360-3016(02)02929-2. [DOI] [PubMed] [Google Scholar]
  • 23.Graham M.V., Purdy J.A., Emami B. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non small cell lung cancer. Int J Radiat Oncol Biol Phys. 1999;45(2):323–329. doi: 10.1016/s0360-3016(99)00183-2. [DOI] [PubMed] [Google Scholar]
  • 24.Hernando M.L., Marks L.B., Bentel G.C. Radiationinduced pulmonary toxicity: a dose–volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys. 2001;51(3):650–659. doi: 10.1016/s0360-3016(01)01685-6. [DOI] [PubMed] [Google Scholar]
  • 25.Marks L.B., Kocak Z., Zhou S. The association between the mean heart dose, mean lung dose, tumor location and RT associated heart and lung toxicity. Int J Radiat Oncol Biol Phys. 2005;63(2):S42. [Google Scholar]
  • 26.McGale P., Darby S.C. Low doses of ionising radiation and circulatory diseases: a systematic review of the published epidemiological evidence. Radiat Res. 2005;163(3):247–257. doi: 10.1667/rr3314. [DOI] [PubMed] [Google Scholar]
  • 27.Preston D.L., Shimizu Y., Pierce D.A., Suyama A., Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950–1997. Radiat Res. 2003;160(4):381–407. doi: 10.1667/rr3049. [DOI] [PubMed] [Google Scholar]
  • 28.Carr Z.A., Land C.E., Kleinerman R.A. Coronary heart disease after radiotherapy for peptic ulcer disease. Int J Radiat Oncol Biol Phys. 2005;61(3):842–850. doi: 10.1016/j.ijrobp.2004.07.708. [DOI] [PubMed] [Google Scholar]
  • 29.Garza R., Albuquerque K., Sethi A. Lung and cardiac tissue doses in left breast cancer patients treated with single-source breast brachytherapy compared to external beam tangent fields. Brachytherapy. 2006;5:235–238. doi: 10.1016/j.brachy.2006.08.001. [DOI] [PubMed] [Google Scholar]
  • 31.Early Breast Cancer Trialists’ Collaborative Group Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer. Lancet. 2000;355:1757–1770. [PubMed] [Google Scholar]
  • 32.Cuzick H., Stewart L., Rutqvist J. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 1994;12:447–453. doi: 10.1200/JCO.1994.12.3.447. [DOI] [PubMed] [Google Scholar]
  • 33.Hall E.J., Wuu C.S. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys. 2003;56(1):83–88. doi: 10.1016/s0360-3016(03)00073-7. [DOI] [PubMed] [Google Scholar]
  • 34.Wazer D.E., Kaufman S., Cuttino L., DiPetrillo T., Arthur D.W. Accelerated partial breast irradiation-an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2006;64(2):489–495. doi: 10.1016/j.ijrobp.2005.06.028. [DOI] [PubMed] [Google Scholar]
  • 35.Vicini F.A., Chen P., Wallace M. Interim cosmetic results and toxicity using 3d conformal external beam radiotherapy to deliver APBI in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2007;69(4):1124–1130. doi: 10.1016/j.ijrobp.2007.04.033. [DOI] [PubMed] [Google Scholar]
  • 36.Slampa P., Rzickova J., Ondrova B., Ticha H., dolezelova H. Sole conformal periooperative interstitial brachytherapy of early stage breast carcinoma using high dose rate after loading: longer-term results and toxicity. Rep Pract Oncol Radiother. 2008;13(2):63–68. [Google Scholar]
  • 37.Rosenstein B.S., Lymberois S.C., Formeti S.C. Biologic comparison of partial breast irradiation protocols. Int J Ratiat Oncol Biol Phys. 2004;60:1393–1404. doi: 10.1016/j.ijrobp.2004.05.072. [DOI] [PubMed] [Google Scholar]
  • 38.Fisher B., Anderson S., Bryant J. Twenty year follow up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–1241. doi: 10.1056/NEJMoa022152. [DOI] [PubMed] [Google Scholar]

Articles from Reports of Practical Oncology and Radiotherapy are provided here courtesy of Via Medica sp. z o.o. sp. k.

RESOURCES